Hawaii 2022 Regular Session

Hawaii Senate Bill SR145 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	THE SENATE S.R. NO. 145 THIRTY-FIRST LEGISLATURE, 2022 STATE OF HAWAII SENATE RESOLUTION Requesting the auditor to ASsess the social and financial effects of mandating health insurance coverage for oocyte cryopreservation.
2	2
3	3	THE SENATE S.R. NO. 145
4	4	THIRTY-FIRST LEGISLATURE, 2022
5	5	STATE OF HAWAII
6	6
7	7	THE SENATE
8	8
9	9	S.R. NO.
10	10
11	11	145
12	12
13	13	THIRTY-FIRST LEGISLATURE, 2022
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29	SENATE RESOLUTION
30	30
31	31
32	32
33	33
34	34
35	35	Requesting the auditor to ASsess the social and financial effects of mandating health insurance coverage for oocyte cryopreservation.
36	36
37	37
38	38
39	39
40	40
41	41	WHEREAS, women who undergo certain procedures such as chemotherapy and surgery, or who are at risk of premature ovarian failure or ovarian disease, have a high risk of infertility; and WHEREAS, health insurers are currently not required to cover procedures for oocyte cryopreservation, or egg freezing; and WHEREAS, S.B. No. 2917, S.D. 2, introduced during the Regular Session of 2022, requires health insurers, mutual benefit societies, and health maintenance organizations that provide coverage for health care to provide coverage for oocyte cryopreservation procedures; and WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, there shall be concurrent resolutions passed that designates a specific legislative bill for the Auditor to review and on which to prepare a report for submission to the Legislature that assesses both the social and financial effects of the proposed mandated coverage, and S.B. No. 2917, S.D. 2 (2022), is such a measure; now, therefore, BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Auditor is requested to conduct an assessment, pursuant to sections 23-51 and 23-52, Hawaii Revised Statutes, of the social and financial effects of mandating health insurance coverage for oocyte cryopreservation procedures, as proposed in S.B. No. 2917, S.D. 2, which was introduced during the Regular Session of 2022; and BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2023; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner. OFFERED BY: _____________________________ Report Title: Insurance; Oocyte Cryopreservation; Auditor
42	42
43	43	WHEREAS, women who undergo certain procedures such as chemotherapy and surgery, or who are at risk of premature ovarian failure or ovarian disease, have a high risk of infertility; and
44	44
45	45
46	46
47	47	WHEREAS, health insurers are currently not required to cover procedures for oocyte cryopreservation, or egg freezing; and
48	48
49	49
50	50
51	51	WHEREAS, S.B. No. 2917, S.D. 2, introduced during the Regular Session of 2022, requires health insurers, mutual benefit societies, and health maintenance organizations that provide coverage for health care to provide coverage for oocyte cryopreservation procedures; and
52	52
53	53
54	54
55	55	WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, there shall be concurrent resolutions passed that designates a specific legislative bill for the Auditor to review and on which to prepare a report for submission to the Legislature that assesses both the social and financial effects of the proposed mandated coverage, and S.B. No. 2917, S.D. 2 (2022), is such a measure; now, therefore,
56	56
57	57
58	58
59	59	BE IT RESOLVED by the Senate of the Thirty-first Legislature of the State of Hawaii, Regular Session of 2022, that the Auditor is requested to conduct an assessment, pursuant to sections 23-51 and 23-52, Hawaii Revised Statutes, of the social and financial effects of mandating health insurance coverage for oocyte cryopreservation procedures, as proposed in S.B. No. 2917, S.D. 2, which was introduced during the Regular Session of 2022; and
60	60
61	61
62	62
63	63	BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of its findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2023; and
64	64
65	65
66	66
67	67	BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner.
68	68
69	69
70	70
71	71
72	72
73	73
74	74
75	75	OFFERED BY: _____________________________
76	76
77	77
78	78
79	79	OFFERED BY:
80	80
81	81	_____________________________
82	82
83	83
84	84
85	85
86	86
87	87	Report Title:
88	88
89	89	Insurance; Oocyte Cryopreservation; Auditor